Gamma Gap: A Point-of-Care Test That Correlates With Disease Burden and Treatment Response in Multiple Myeloma A total of 12,221 patients (median age, 75.6 years; 40.9% women, 87.6% white) were ...
The recent surge of drug approvals in the non-small cell lung cancer (NSCLC) space by the Food and Drug Administration (FDA) is quite unusual and only a fraction of them are considered practice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results